Abstract:The β1-adrenoceptor (β1AR) is a G-protein-coupled receptor (GPCR) that couples<a href="/articles/s41586-020-2419-1#ref-CR1">1</a> to the heterotrimeric G protein Gs. G-protein-mediated signalling is terminated by phosphorylation of the C terminus of the receptor by GPCR kinases (GRKs) and by coupling of β-arrestin 1 (βarr1, also known as arrestin 2), which displaces Gs and induces signalling through the MAP kinase pathway<a href="/articles/s41586-020-2419-1#ref-CR2">2</a>. The ability of synthetic agonists to induce signalling preferentially through either G proteins or arrestins—known as biased agonism<a href="/articles/s41586-020-2419-1#ref-CR3">3</a>—is important in drug development, because the therapeutic effect may arise from only one signalling cascade, whereas the other pathway may mediate undesirable side effects<a href="/articles/s41586-020-2419-1#ref-CR4">4</a>. To understand the molecular basis for arrestin coupling, here we determined the cryo-electron microscopy structure of the β1AR–βarr1 complex in lipid nanodiscs bound to the biased agonist formoterol<a href="/articles/s41586-020-2419-1#ref-CR5">5</a>, and the crystal structure of formoterol-bound β1AR coupled to the G-protein-mimetic nanobody<a href="/articles/s41586-020-2419-1#ref-CR6">6</a> Nb80. βarr1 couples to β1AR in a manner distinct to that<a href="/articles/s41586-020-2419-1#ref-CR7">7</a> of Gs coupling to β2AR—the finger loop of βarr1 occupies a narrower cleft on the intracellular surface, and is closer to transmembrane helix H7 of the receptor when compared with the C-terminal α5 helix of Gs. The conformation of the finger loop in βarr1 is different from that adopted by the finger loop of visual arrestin when it couples to rhodopsin<a href="/articles/s41586-020-2419-1#ref-CR8">8</a>. β1AR coupled to βarr1 shows considerable differences in structure compared with β1AR coupled to Nb80, including an inward movement of extracellular loop 3 and the cytoplasmic ends of H5 and H6. We observe weakened interactions between formoterol and two serine residues in H5 at the orthosteric binding site of β1AR, and find that formoterol has a lower affinity for the β1AR–βarr1 complex than for the β1AR–Gs complex. The structural differences between these complexes of β1AR provide a foundation for the design of small molecules that could bias signalling in the β-adrenoceptors.

Different conformational responses of the β2-adrenergic receptor-Gs complex upon binding of the partial agonist salbutamol or the full agonist isoprenaline

Different conformational responses of the <sub>2</sub>-adrenergic receptor-Gs complex upon binding of the partial agonist salbutamol or the full agonist isoprenaline

Structures of β1-adrenergic receptor in complex with Gs and ligands of different efficacies

Distinct Conformations of GPCR–β-arrestin Complexes Mediate Desensitization, Signaling, and Endocytosis

Single Hormone or Synthetic Agonist Induces Gs/Gi Coupling Selectivity of EP Receptors Via Distinct Binding Modes and Propagating Paths.

Structural Insights into Angiotensin Receptor Signaling Modulation by Balanced and Biased Agonists.

Computational study on the different ligands induced conformation change of β2 adrenergic receptor-Gs protein complex.

Studies on the Interactions Between Β2adrenergic Receptor and Gs Protein by Molecular Dynamics Simulations

Structural insights into binding specificity, efficacy and bias of a β2AR partial agonist

Distinct Structural Changes in a G Protein-coupled Receptor Caused by Different Classes of Agonist Ligands

Distinct binding conformations of epinephrine with α- and β-adrenergic receptors

Constrained catecholamines gain β2AR selectivity through allosteric effects on pocket dynamics

Molecular basis of β-arrestin coupling to formoterol-bound β1-adrenoceptor

Conformational changes in the G protein Gs induced by the β2 adrenergic receptor

Stereochemistry Of An Agonist Determines Coupling Preference Of Beta(2)-Adrenoceptor To Different G Proteins In Cardiomyocytes

Understanding the Effects on Constitutive Activation and Drug Binding of a D130N Mutation in the Β2 Adrenergic Receptor Via Molecular Dynamics Simulation

Structural Features and Ligand Selectivity for 10 Intermediates in the Activation Process of Β2-Adrenergic Receptor

Binding kinetics drive G protein subtype selectivity at the β1-adrenergic receptor

Understanding the Conformation Transition in the Activation Pathway of Β2 Adrenergic Receptor Via a Targeted Molecular Dynamics Simulation.

Targeted transgenesis identifies Gαs as the bottleneck in β2-adrenergic receptor cell signaling and physiological function in airway smooth muscle

Multiple Ligand-Specific Conformations of the Β2-Adrenergic Receptor